Funding Decisions

Round Based Channel

Overview of previous funding rounds:
Rounds: 9 | 8 | 7 | 6 | 5 | 4 | 3 | 2 | 1

Rolling Continuation Channel (RCC)

Overview of previous funding waves:
Waves: 6 | 5 | 4 | 3 | 2 | 1

Affordable Medicines Facility - malaria (AMFm)

Overview of previous funding phases:
Phases: 1


Following the review of 9 proposal rounds:

Round 9 and NSA - November 2009*

Total  

90 Round 9 disease proposals (including HSS requests) and National Strategy Applications (NSA) in 69 different countries approved, in principle, by the Board on 10 November 2009. It is noted that the TRP funding recommendations are collectively intended to be subject to a 10% adjustment downwards for efficiency, resulting in an adjusted maximum Phase 1 upper-ceiling funding of US$ 2.38 billion.

     
By Region  

East Asia & the Pacific - US$ 473.6** million for 12 disease proposals (including HSS requests) in 7 countries
Eastern Europe & Central Asia - US$ 107.6** million for 12 disease proposals in 10 countries
Latin America & the Caribbean - US$ 185.5** million for 17 disease proposals (including HSS requests) in 14 countries
North Africa & the Middle East - US$ 87.3** million for 5 disease proposals (including HSS requests) in 5 countries
South West Asia - US$ 233.8** million for 8 disease proposals (including HSS requests) in 6 countries
Sub-Saharan Africa: East Africa - US$ 709.4** million for 11 disease proposals (including HSS requests) in 9 countries
Sub-Saharan Africa: Southern Africa - US$ 258.9** million for 7 disease proposals in 6 countries
Sub-Saharan Africa: West & Central Africa - US$ 592.1** million for 18 disease proposals (including HSS requests) in 12 countries

     
By Disease   HIV US$ 1,198** million in 36 countries
Tuberculosis US$ 666.6** million in 35 countries
Malaria US$ 783.1** million in 19 countries
   
Documentation  
TRP Funding Recommendations: Round 9 | NSA
Full List of Approved Proposals: Round 9 | NSA
Proposals Not Approved: Round 9 and NSA

Board Decision Point on Round 9 and NSA (GF/B20/DP11):
English - PDF - 260 KB

     
   

* USD exchange rate November 2009.

** Please note that amounts per region and disease do not include a 10% downward adjustment for efficiency anticipated to be achieved during TRP clarifications and grant negotiations.

back to top

Round 8 - November 2008

Total   110 programs in 68 countries approved in principle 8 November 2008 . It is noted that the Round 8 proposals are collectively intended to be subject to a 10% adjustment downwards for efficiency, resulting in an adjusted maximum Phase 1 upper ceiling funding of US$2.753 billion.
     
By Region  

East Asia & the Pacific - US$ 387.4* million for 17 programs in 9 countries
Eastern Europe & Central Asia - US$ 141.9* million for 16 programs in 9 countries
Latin America & the Caribbean - US$ 161.9* million for 11 programs in 10 countries
North Africa & the Middle East - US$ 147.4* million for 10 programs in 7 countries
South Asia - US $ 98.3* million for 8 programs in 5 countries
Sub-Saharan Africa: East Africa - US$ 796.1* million for 15 programs in 10 countries
Sub-Saharan Africa: Southern Africa - US$ 414.0* million for 13 programs in 5 countries
Sub-Saharan Africa: West & Central Africa - US$ 912.3* million for 20 programs in 13 countries

     
By Disease   HIVUS$ 1,164* million for programs in 37 countries
Malaria US$ 1,568* million programs in 28 countries
Tuberculosis US$ 327* million for programs in 29 countries
   
Documentation  

TRP Funding Recommendations
Full List of Approved Proposals
Proposals Not Approved

     
   

* Please note that amounts per region and disease do not include a 10% downward adjustment for efficiency anticipated to be achieved during TRP clarifications and grant negotiations.

back to top

Round 7 - November 2007

Total   Total approved US$ 1,119 million 73 programs in 66 countries/economies*
     
By Region  

East Asia & the Pacific - US$ 92 million for 11 programs in 19 countries/ economies*
Eastern Europe & Central Asia - US$ 38 million for 5 programs in 5 countries/ economies
Latin America & the Caribbean - US$ 54 million for 10 programs in 11 countries/ economies*
North Africa & the Middle East - US$ 164 million for 10 programs in 7 countries/ economies
South Asia - US $97 million for 9 programs in 6 countries/economies
Sub-Saharan Africa: East Africa - US$ 385 million for 9 programs in 8 countries/ economies
Sub-Saharan Africa: Southern Africa - US$ 154 million for 8 programs in 6 countries/economies
Sub-Saharan Africa: West & Central Africa - US$ 134 million for 11 programs in 8 countries/economies

     
By Disease   HIV US$ 537 million for 26 programs in 39 countries/economies*
Malaria US$ 471 million for 28 programs in 27 countries/economies
Tuberculosis US$ 111 million for 19 programs in 30 countries/economies*
   
Documentation  

TRP Funding Recommendations
Full List of Approved Proposals
Proposals Not Approved

Guidelines PDF - 700 KB | Form DOC - 3 MB

    *Including countries/economies targeted in the multi – country proposal

back to top

Round 6 - November 2006

Total   Total approved US$ 846 million in 63 countries
     
By Region  

East Asia & the Pacific - US$ 107 million in 8 countries
Eastern Europe & Central Asia - US$ 119 million in 12 country
Latin America & the Caribbean - US$ 47 million in 4 countries
North Africa & the Middle East - US$ 70 million in 9 countries
South Asia - US$ 129 million in 5 countries
Sub-Saharan Africa: East Africa - US$ 94 million in 7 countries
Sub-Saharan Africa: Southern Africa - US$ 117 million in 4 countries
Sub-Saharan Africa: West & Central Africa - US$ 159 million in 14 countries

     
By Disease   HIV US$ 453 million in 34 countries
Malaria US$ 202 million in 19 countries
Tuberculosis US$ 190 million in 34 countries
   
Documentation  

TRP Funding Recommendations | Full List of Approved Proposals
List of Successful Appeals

Guidelines PDF - 378 KB | Form DOC - 2.56 MB

back to top

Round 5 - September 2005

Total   Total approved US$ 770 million in 60 countries
     
By Region  

East Asia & the Pacific - US$ 128 million in 17 countries
Eastern Europe & Central Asia - US$ 27 million in 8 country
Latin America & the Caribbean - US$ 54 million in 4 countries
North Africa & the Middle East - US$ 63 million in 4 countries
South Asia - US$ 24 million in 2 countries
Sub-Saharan Africa: East Africa - US$ 135 million in 5 countries
Sub-Saharan Africa: Southern Africa - US$ 124 million in 8 countries
Sub-Saharan Africa: West & Central Africa - US$ 210 million in 12 countries

     
By Disease   HIV US$ 315 million in 25 countries
HSS US$ 38 million in 3 countries
Malaria US$ 202 million in 26 countries
Tuberculosis US$ 213 million in 23 countries
   
Documentation  

TRP Funding Recommendations | Full List of Approved Proposals
List of Successful Appeals

Guidelines PDF - 183 KB | Form DOC - 585 KB

back to top

Round 4 - June 2004

Total   Total approved US$ 1,039 million in 52 countries
     
By Region   Africa - US$ 663 million for 34 programs in 23 countries
Asia, Middle East & North Africa - US$237 million for 23 programs in 16 countries
Latin America, Caribbean & Eastern Europe - US$ 139 million for 15 programs in 13 countries
     
By Disease   HIV US$ 469 m in 27 countries
Malaria US$ 417 m in 23 countries
Tuberculosis US$ 153 m in 21 countries
   
Documentation  

TRP Funding Recommendations | Full List of Approved Proposals
List of Successful Appeals

Guidelines PDF - 82 KB | Form PDF - 208 KB

back to top

Round 3 - November 2003

Total   US$ 623m for 71 programs in 61 countries
     
By Region   Africa - US$ 365m for 34 programs in 23 countries
Asia, Middle East & North Africa - US$ 127m for 15 programs in 13 countries
Latin America, Caribbean & Eastern Europe - US$ 130m for 22 programs in 25 countries
     
By Disease   HIV US$ 362m for 31 programs in 52 countries
HIV/TB US$ 27m for 2 programs in 2 countries
Malaria US$ 166m for 20 programs in 20 countries
Tuberculosis US$ 68m for 18 programs in 18 countries
   
Documentation  

TRP Funding Recommendations | Full List of Approved Proposals
List of Successful Appeals

Guidelines PDF - 110 KB | Form PDF - 174 KB

back to top

Round 2 - January 2003

Total   US$ 866 million for 98 programs in 73 countries
     
By Region   Africa - US$ 550m for 49 programs in 30 countries
Asia, Middle East & North Africa - US$ 145m for 27 programs in 27 countries
Latin America, Caribbean & Eastern Europe - US$ 171m for 22 programs in 16 countries
     
By Disease   HIV US$ 487m for 43 programs in 52 countries
HIV/TB US$ 8m for 1 program in 1 country
Integrated US$ 3m for 1 program in 1 country
Malaria US$ 242m for 28 programs in 37 countries
Tuberculosis US$ 126m for 25 programs in 35 countries
   
Documentation  

TRP Funding Recommendations | Full List of Approved Proposals
List of Successful Appeals

Guidelines PDF - 159 KB | Form PDF - 122 KB

back to top

Round 1 - April 2002

Total   US$ 565 million for 55 programs in 36 countries
     
By Region   Africa - US$ 308m for 27 programs in 16 countries
Asia, Middle East & North Africa - US$ 151m for 18 programs in 11 countries
Latin America, Caribbean & Eastern Europe - US$ 106m for 10 programs in 9 countries
     
By Disease   HIV US$ 326m for 26 programs in 22 countries
HIV/TB US$ 55m for 4 programs in 3 countries
Integrated US$ 20m for 1 program in 1 country
Malaria US$ 68m for 12 programs in 12 countries
Tuberculosis US$ 96m for 12 programs in 12 countries
   
Documentation  

TRP Funding Recommendations | Full List of Approved Proposals
List of Successful Appeals

Guidelines PDF - 48 KB | Form PDF - 58 KB

back to top

Summary of RCC Wave 6 Funding Decisions May 2009

Total   US $552,040,988 in nine countries
     
By Country  

Bangladesh - US$ 81,312,404
Belarus - US$ 14,340,567
Guyana - US$ 47,035,818
India - US$ 302,056,162
Nepal - US$ 31,950,775
Rwanda - US$ 13,700,861
Paraguay - US$ 5,481,613
Russia - EUR 9,288,623
Georgia - EUR 33,338,933

     
By Disease  

HIV and AIDS - US$ 488,669,764
Tuberculosis - US$ 31,420,449
Malaria - US$ 31,950,775

   
Documentation  

TRP Funding Recommendations
Full List of Approved Proposals
Proposals Not Approved

back to top

Summary of RCC Wave 5 Funding Decisions February 2009

Total   US$ 229,193,583 in six countries
     
By Country  

Armenia - US$ 11,906,034
Benin - US$ 60,422,029
China - US$ 205,031,814
Dominican Republic - US$ 6,405,790
Madagascar - US$ 33,798,784
Tajikistan - US$ 4,382,023

     
By Disease  

HIV and AIDS - US$ 216,937,848
Tuberculosis - US$ 10,787,813
Malaria - US$ 94,220,813

   
Documentation  

TRP Funding Recommendations
Full List of Approved Proposals
Proposals Not Approved

back to top

Summary of RCC Wave 4 Funding Decisions October 2008

Total   US $229,193,583 in five countries
     
By Country  

Dominican Republic - US $45,770,388
El Salvador - US$ 14,398,031
Ghana - US$ 89,764,243
India - US$ 72,095,018
Nicaragua - US$ 7,165,903

     
By Disease  

HIV and AIDS - US $60,168,419
Tuberculosis - US$ 79,260,921
Malaria - US$ 89,764,243

   
Documentation  

TRP Funding Recommendations
Full List of Approved Proposals
Proposals Not Approved

back to top

Summary of RCC Wave 3 Funding Decisions July 2008

Total   US$ 513,349,804 in eight countries
     
By Country  

Bulgaria - US $28,021,697
Cambodia - US$ 19,540,113
China - US$ 42,840,814
Cuba - US$ 9,772,998
Ethiopia - US$ 342,574,327
Haiti - US$ 46,136,317
Honduras - US$ 3,453,657
MCWP - US$ 21,009,881

     
By Disease  

HIV and AIDS - US $426,505,339
Tuberculosis - US$ 42,840,814
Malaria - US$ 44,003,651

   
Documentation  

TRP Funding Recommendations
Full List of Approved Proposals
Proposals Not Approved

back to top

Summary of RCC Wave 2 Funding Decisions April 2008

Total   US $364,489,068 in five countries
     
By Country  

Malawi - US$ 173,329,414
Mongolia - US$ 3,481,740
RMCC - US$ 14,384,472
Thailand - US$ 56,157,021
Philippines - US$ 117,136,422

     
By Disease  

HIV and AIDS - US$ 232,968,175
Tuberculosis - US$ 78,037,991
Malaria - US$ 53,482,903

   
Documentation  

TRP Funding Recommendations
Full List of Approved Proposals
Proposals Not Approved

back to top

Summary of RCC Wave 1 Funding Decisions November 2007

Total   US$ 129,713,262 in five countries
     
By Country  

Burundi - US$19,694,151
Honduras - US$ 25,121,194
Mongolia - US$ 3,553,729
Rwanda - US$ 21,346,817
Tanzania - US$ 59,997,371

     
By Disease  

HIV and AIDS - US$ 47,187,023
Tuberculosis - US$ 8,454,963
Malaria - US$ 151,443,365

   
Documentation  

TRP Funding Recommendations
Full List of Approved Proposals

back to top

AMFm Phase 1 - November 2009

Total   10 applications to AMFm Phase 1 were approved on 11 November 2009. The total budget for supporting interventions across these applications was US$126.7 million. Of this, US$ 17.6 was requested in new funding from the Global Fund. The majority of funding for supporting interventions will be provided through reprogramming savings gained in participating countries' existing Global Fund malaria grants through the lower cost of artemisinin-based combination therapies (ACTs) under AMFm.
     
By Region   East Asia & the Pacific - 1 application approved with a total budget for supporting interventions of US$11 million (US$9.6 requested in new funding from the Global Fund)
North Africa & Middle East - 1 application approved with a total budget for supporting interventions of US$2.1 million (US$1.7 million requested in new funding from the Global Fund)
Sub-Saharan Africa: East Africa & Indian Ocean - 6 applications approved with a total budget for supporting interventions of US$47.8 million (US$6.3 million requested in new funding from the Global Fund)
Sub-Saharan Africa: West & Central Africa - 2 applications approved with a total budget for supporting interventions of US$65.8 million (no new funding requested from the Global Fund)
     
   
Documentation  

TRP Funding Recommendations (coming soon)
Full List of Approved Applications
Applications Not Approved